Outbrain Inc
NASDAQ:OB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Outbrain Inc
NASDAQ:OB
|
US |
|
Noront Resources Ltd
XTSX:NOT
|
CA |
|
Vranken Pommery Monopole SA
PAR:VRAP
|
FR |
|
Condor Energies Inc
TSX:CDR
|
CA |
|
B
|
BioDelivery Sciences International Inc
F:BD5
|
US |
|
A
|
Al-Saif Stores for Development & Investment Company SJSC
SAU:4192
|
SA |
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
KR |
|
F
|
FG Merger II Corp
NASDAQ:FGMC
|
US |
|
R
|
Royal Orchid Hotel Thailand PCL
SET:ROH
|
TH |
|
Pharmaust Ltd
ASX:PAA
|
AU |
|
IGEA Pharma NV
SIX:IGPH
|
NL |
|
Chaoda Modern Agriculture Holdings Ltd
HKEX:682
|
HK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OB's stock price target?
Not Available
OB doesn't have any price targets made by Wall Street professionals.
What is Outbrain Inc's Revenue forecast?
Projected CAGR
9%
For the last 4 years the
compound annual growth rate for
Outbrain Inc's revenue is
4%.
The projected
CAGR
for the next 3 years is
9%.